Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]
Clinical trial NCT02780700 · TERMINATED
Trial details
- NCT number
- NCT02780700
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-05
- Primary completion
- 2016-09-09
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.